Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

被引：0
|
作者：
Sergio Granados-Principal
Yi Liu
Maria L Guevara
Elvin Blanco
Dong Soon Choi
Wei Qian
Tejal Patel
Angel A Rodriguez
Joseph Cusimano
Heidi L Weiss
Hong Zhao
Melissa D Landis
Bhuvanesh Dave
Steven S Gross
Jenny C Chang
机构：
[1] Methodist Cancer Center,Department of Nanomedicine
[2] Houston Methodist Hospital,Department of Chemistry and Biochemistry
[3] Medical and Health Sciences College,Biostatistics Shared Resource Facility, Markey Cancer Center
[4] Monterrey Institute of Technology,Department of Systems Medicine and Bioengineering
[5] Houston Methodist Research Institute,undefined
[6] Arizona State University,undefined
[7] University of Kentucky,undefined
[8] Houston Methodist Research Institute,undefined
[9] Weill Cornell Medical College,undefined
来源：
Breast Cancer Research | / 17卷
关键词：
Docetaxel; Endoplasmic Reticulum Stress; Amlodipine; iNOS Expression; TNBC Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
    Manish Charan
    Subhadip Das
    Sanjay Mishra
    Nabanita Chatterjee
    Sanjay Varikuti
    Kirti Kaul
    Swati Misri
    Dinesh K. Ahirwar
    Abhay R. Satoskar
    Ramesh K. Ganju
    Cell Death & Disease, 11
  • [42] Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer
    Skor, Maxwell N.
    Wonder, Erin L.
    Kocherginsky, Masha
    Goyal, Anju
    Hall, Ben A.
    Cai, Yi
    Conzen, Suzanne D.
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6163 - 6172
  • [43] Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer
    Ludwik, Katarzyna A.
    Campbell, J. Preston
    Li, Mingzong
    Li, Yu
    Sandusky, Zachary M.
    Pasic, Lejla
    Sowder, Miranda E.
    Brenin, David R.
    Pietenpol, Jennifer A.
    O'Doherty, George A.
    Lannigan, Deborah A.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2598 - 2608
  • [44] Novel Therapies for Triple-Negative Breast Cancer
    Nanda, Rita
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (12) : 799 - 801
  • [45] Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
    Duncan, James S.
    Whittle, Martin C.
    Nakamura, Kazuhiro
    Abell, Amy N.
    Midland, Alicia A.
    Zawistowski, Jon S.
    Johnson, Nancy L.
    Granger, Deborah A.
    Jordan, Nicole Vincent
    Darr, David B.
    Usary, Jerry
    Kuan, Pei-Fen
    Smalley, David M.
    Major, Ben
    He, Xiaping
    Hoadley, Katherine A.
    Zhou, Bing
    Sharpless, Norman E.
    Perou, Charles M.
    Kim, William Y.
    Gomez, Shawn M.
    Chen, Xin
    Jin, Jian
    Frye, Stephen V.
    Earp, H. Shelton
    Graves, Lee M.
    Johnson, Gary L.
    CELL, 2012, 149 (02) : 307 - 321
  • [46] PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
    Horiuchi, Dai
    Camarda, Roman
    Zhou, Alicia Y.
    Yau, Christina
    Momcilovic, Olga
    Balakrishnan, Sanjeev
    Corella, Alexandra N.
    Eyob, Henok
    Kessenbrock, Kai
    Lawson, Devon A.
    Marsh, Lindsey A.
    Anderton, Brittany N.
    Rohrberg, Julia
    Kunder, Ratika
    Bazarov, Alexey V.
    Yaswen, Paul
    McManus, Michael T.
    Rugo, Hope S.
    Werb, Zena
    Goga, Andrei
    NATURE MEDICINE, 2016, 22 (11) : 1321 - 1329
  • [47] Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer
    Chen, Yao
    Yang, Jirui
    Wang, Chuanqi
    Wang, Tianbao
    Zeng, Yingjie
    Li, Xiao
    Zuo, Yi
    Chen, Hongyu
    Zhang, Chaozheng
    Cao, Yuening
    Sun, Chen
    Wang, Maolin
    Cao, Xiujun
    Ge, Xian
    Liu, Yilan
    Zhang, Ge
    Deng, Yun
    Peng, Cheng
    Lu, Aiping
    Lu, Jun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [48] Development of novel targeted adjuvant therapy for triple negative breast cancer
    Bansal, Nidhi
    Farias, Eduardo
    Gonzalez, Veronica
    Nolan, Garry
    Waxman, Samuel
    CANCER RESEARCH, 2017, 77
  • [49] PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
    Dai Horiuchi
    Roman Camarda
    Alicia Y Zhou
    Christina Yau
    Olga Momcilovic
    Sanjeev Balakrishnan
    Alexandra N Corella
    Henok Eyob
    Kai Kessenbrock
    Devon A Lawson
    Lindsey A Marsh
    Brittany N Anderton
    Julia Rohrberg
    Ratika Kunder
    Alexey V Bazarov
    Paul Yaswen
    Michael T McManus
    Hope S Rugo
    Zena Werb
    Andrei Goga
    Nature Medicine, 2016, 22 : 1321 - 1329
  • [50] Inhibition of fatty-acid oxidation as a therapy for triple-negative breast cancer
    Goga, A.
    Camarda, R.
    Zhou, A. Y.
    Kohnz, R. A.
    Balakrishnan, S.
    Anderton, B.
    Mahieu, C.
    Eyob, H.
    Krings, G.
    Nomura, D. K.
    CANCER RESEARCH, 2016, 76
12345